Health

FDA clears oral antibiotic gepotidacin for uncomplicated UTIs in women, offering a novel option amid rising resistance.

The US reports its first human death from H5N1 bird flu, raising urgent questions about pandemic preparedness and viral mutations.

A new study finds microplastics in human testicles, linking them to declining sperm counts and fertility issues.

FDA halts trial of experimental Alzheimer's drug due to liver toxicity concerns.

A clinical trial for a CRISPR-based blindness treatment was halted after severe side effects emerged in multiple patients.

The CDC issued a health alert yesterday after detecting a novel H5N1 mutation in a Louisiana patient, raising pandemic concerns.

The FDA suzetrigine approval is a landmark moment in pain management, offering a non-addictive alternative to opioids.

New FDA investigation into semaglutide drugs like Ozempic finds possible suicide risk signal, raising questions about GLP-1 safety monitoring.

FDA approves new Alzheimer's drug donanemab, a monoclonal antibody that targets amyloid plaques. Eli Lilly stock jumps 4.2% on the news.

Genetic sequencing reveals H5N1 mutation in a US patient, increasing risk of human-to-human transmission. Experts urge vigilance.

CRISPR sickle cell approval is historic, but the FDA's black-box warning over off-target edits raises safety questions.

FDA advisory panel voted against recommending LSD-assisted therapy for generalized anxiety disorder, citing insufficient efficacy data and safety concerns.